Commentary - (2016) Volume 2, Issue 2
Targeting Monocytes with TLR7 Ligands as a Novel Opportunity in Immuno-Oncology
- Simon S Jensen1,3*, Ladan Parhamifar1,3, Jonas Henriksen1,2,3 and Thomas L Andresen1
- 1Department of Micro and Nanotechnology, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, DK-2800, Denmark
- 2Department of Chemistry, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, DK-2800, Denmark
- 3MonTa Biosciences, Produktionstorvet, Kgs. Lyngby, DK-2800, Denmark
*Corresponding Author:
Simon S Jensen, Department of Micro and Nanotechnology, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, DK-2800, Denmark, Tel: 4545258121
Email:
